rs35766971

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006073.4(TRDN):​c.1016G>A​(p.Ser339Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,591,380 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S339R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.011 ( 37 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 35 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.92

Publications

5 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN-AS1 (HGNC:40592): (TRDN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023744404).
BP6
Variant 6-123438098-C-T is Benign according to our data. Variant chr6-123438098-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1736/152186) while in subpopulation AFR AF = 0.0385 (1599/41530). AF 95% confidence interval is 0.0369. There are 37 homozygotes in GnomAd4. There are 793 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.1016G>A p.Ser339Asn missense_variant Exon 12 of 41 ENST00000334268.9 NP_006064.2 Q13061-1
TRDNNM_001251987.2 linkc.1019G>A p.Ser340Asn missense_variant Exon 12 of 21 NP_001238916.1 A0A590UJV0Q8IVK2
TRDNNM_001407315.1 linkc.959G>A p.Ser320Asn missense_variant Exon 11 of 20 NP_001394244.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.1016G>A p.Ser339Asn missense_variant Exon 12 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1
TRDNENST00000662930.1 linkc.1019G>A p.Ser340Asn missense_variant Exon 12 of 21 ENSP00000499585.1 A0A590UJV0
TRDN-AS1ENST00000587106.6 linkn.572-1505C>T intron_variant Intron 6 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1734
AN:
152068
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00733
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00271
AC:
594
AN:
219566
AF XY:
0.00201
show subpopulations
Gnomad AFR exome
AF:
0.0371
Gnomad AMR exome
AF:
0.00228
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000297
Gnomad OTH exome
AF:
0.00167
GnomAD4 exome
AF:
0.00107
AC:
1534
AN:
1439194
Hom.:
35
Cov.:
30
AF XY:
0.000887
AC XY:
634
AN XY:
714934
show subpopulations
African (AFR)
AF:
0.0386
AC:
1232
AN:
31948
American (AMR)
AF:
0.00296
AC:
116
AN:
39196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25482
East Asian (EAS)
AF:
0.0000764
AC:
3
AN:
39288
South Asian (SAS)
AF:
0.0000245
AC:
2
AN:
81704
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52440
Middle Eastern (MID)
AF:
0.00159
AC:
9
AN:
5666
European-Non Finnish (NFE)
AF:
0.0000217
AC:
24
AN:
1104036
Other (OTH)
AF:
0.00249
AC:
148
AN:
59434
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1736
AN:
152186
Hom.:
37
Cov.:
32
AF XY:
0.0107
AC XY:
793
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0385
AC:
1599
AN:
41530
American (AMR)
AF:
0.00739
AC:
113
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67994
Other (OTH)
AF:
0.0104
AC:
22
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
94
189
283
378
472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00420
Hom.:
31
Bravo
AF:
0.0129
ESP6500AA
AF:
0.0334
AC:
123
ESP6500EA
AF:
0.000123
AC:
1
ExAC
AF:
0.00322
AC:
388
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Nov 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser340Asn in exon 12 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 3.3% (123/3682) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs35766971). -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 15, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TRDN-related disorder Benign:1
Mar 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Aug 04, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Nov 01, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.42
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N
PhyloP100
1.9
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.070
Sift
Uncertain
0.0080
D
Sift4G
Benign
0.48
T
Polyphen
0.089
B
Vest4
0.11
MVP
0.22
ClinPred
0.0060
T
GERP RS
3.7
Varity_R
0.079
gMVP
0.0055
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35766971; hg19: chr6-123759243; COSMIC: COSV62119335; COSMIC: COSV62119335; API